Coronavirus (COVID-19) Visitor Policy & Advisory: Adventist HealthCare is taking appropriate steps to protect the safety of our patients, caregivers and community. Learn More
Emergency Room Wait Times
Home > Clinical Trials > Clinical Trial Search Results
In this study, participants with multiple types of advanced solid tumors that have progressed on standard of care therapy will be treated with pembrolizumab.
This study will evaluate the efficacy and safety of atezolizumab compared with placebo as adjuvant therapy after definitive local therapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck (SCCHN)
The purpose of this study is to investigate experimental medication BMS-986253 in combination with Nivolumab in patients with advanced cancers.
Find an Adventist HealthCare affiliated doctor by calling our FREE physician referral service at 800-642-0101 or by searching our online physician directory.
Set Your Location
Setting your location helps us to show you nearby providers and locations based on your healthcare needs.